China Universal Asset Management »

Syndax Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $389k 16k 23.81
2023-12-31 $174k 8.1k 21.59
2023-09-30 $26k 1.8k 14.59
2023-06-30 $19k 902 21.06
2023-03-31 $20k 928 21.55
2022-12-31 $16k 612 26.14
2022-09-30 $13k 530 24.53

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals